4-Bromo-5-(pyrrolidin-1-yl)pyridazin-3(2H)-one

Catalog No. :
ACSKIW180
CAS No. :
692749-93-2
Molecular Formula :
C8H10BrN3O
Molecular Weight :
244.09

IUPAC Name:4-bromo-5-(pyrrolidin-1-yl)pyridazin-3(2H)-one

4-Bromo-5-(pyrrolidin-1-yl)pyridazin-3(2H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$98.00Login to see priceInquiryInquiry
1g98%$215.00Login to see priceInquiryInquiry
5g98%$800.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Bromo-5-(pyrrolidin-1-yl)pyridazin-3(2H)-one
IUPAC Name4-bromo-5-(pyrrolidin-1-yl)pyridazin-3(2H)-one
MDL No.MFCD03617663
Molecular FormulaC8H10BrN3O
Molecular Weight244.09
SMILESO=C1C(Br)=C(N2CCCC2)C=NN1
InChI KeyVQDGSEAYARKYIA-UHFFFAOYSA-N
Synonym4-bromo-5-(1-pyrrolidinyl)-3(2H)-pyridazinone(SALTDATA: FREE);4-bromo-5-(1-pyrrolidinyl)-3(2H)-pyridazinone(SALTDATA: FREE) ISO 9001:2015 REACH;3(2H)-Pyridazinone, 4-bromo-5-(1-pyrrolidinyl)-;4-Bromo-5-(pyrrolidin-1-yl)pyridazin-3(2H)-one
CAS No.692749-93-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACSKIW180 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSKIW180 route product structure diagram
    ACSKIW180692749-93-2
Inquiry

2. ACSKIW180 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOEFY632 route compound structure diagram
    ACOEFY6325788-58-9 In Stock
  4. Then
  5. ACSKIW180 route product structure diagram
    ACSKIW180692749-93-2
Inquiry

Comments (0)